FDA BeSafeRx

Bizzell recently completed the BeSafeRx Relaunch for the U.S. Food and Drug Administration (FDA). BeSafeRx is a national campaign sponsored by FDA to educate consumers and healthcare providers about the potential dangers of buying prescription medicine online and provide important information about purchasing medicine safely online.

There are significant public health risks of consumers who may buy from illegal websites that offer prescription medicine. Many of these online pharmacies (95%) are unsafe or unlicensed. Some drugs sold online may be dangerous to consumers as they can be counterfeit, have the wrong ingredients, or have harmful side effects. In the current environment where communities are faced with challenges due to the COVID-19 pandemic, consumer behavior has shifted resulting in more people using the internet to make purchases for essentials like food, household supplies, and medicine. Because of this, the relaunch of BeSafeRx is even more critical/timely to ensure the health and wellbeing of the American public.

Bizzell leveraged historical FDA information, data, insights, and reports to develop updated BeSafeRx content and messaging that is clear, relevant, and aligned with FDA’s visual identity and brand guidelines. As a part of the contract, Bizzell also conducted the following:
Updated web messaging based on testing/research with target audiences
Updated web content using best practices in UX/UI design
Developed new visual theme to connect creative assets to campaign messaging/content
Designed new print collateral for consumers and health professionals
Developed digital toolkit for FDA social media channels (Facebook, Twitter, LinkedIn)
Produced 2-minute and 30-second PSA animated videos/audio (YouTube, TV, Radio)
508 Compliance Remediation